- Home
- BKU vs COGT Comparison
BKU vs COGT Comparison
Compare BKU & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKU
- COGT
- Stock Information
- Founded
- BKU 2009
- COGT 2014
- Country
- BKU United States
- COGT United States
- Employees
- BKU N/A
- COGT N/A
- Industry
- BKU Savings Institutions
- COGT Biotechnology: Pharmaceutical Preparations
- Sector
- BKU Finance
- COGT Health Care
- Exchange
- BKU Nasdaq
- COGT Nasdaq
- Market Cap
- BKU 2.8B
- COGT 2.3B
- IPO Year
- BKU 2011
- COGT 2018
- Fundamental
- Price
- BKU $40.68
- COGT $33.02
- Analyst Decision
- BKU Hold
- COGT Buy
- Analyst Count
- BKU 12
- COGT 13
- Target Price
- BKU $41.67
- COGT $25.67
- AVG Volume (30 Days)
- BKU 1.1M
- COGT 3.9M
- Earning Date
- BKU 10-22-2025
- COGT 11-03-2025
- Dividend Yield
- BKU 3.06%
- COGT N/A
- EPS Growth
- BKU 44.85
- COGT N/A
- EPS
- BKU 3.54
- COGT N/A
- Revenue
- BKU $1,016,093,000.00
- COGT N/A
- Revenue This Year
- BKU $14.68
- COGT N/A
- Revenue Next Year
- BKU $5.82
- COGT N/A
- P/E Ratio
- BKU $11.44
- COGT N/A
- Revenue Growth
- BKU 10.45
- COGT N/A
- 52 Week Low
- BKU $28.21
- COGT $3.72
- 52 Week High
- BKU $44.45
- COGT $36.15
- Technical
- Relative Strength Index (RSI)
- BKU 60.45
- COGT 88.36
- Support Level
- BKU $39.51
- COGT $13.93
- Resistance Level
- BKU $40.80
- COGT $36.15
- Average True Range (ATR)
- BKU 1.16
- COGT 1.50
- MACD
- BKU 0.16
- COGT 1.62
- Stochastic Oscillator
- BKU 84.43
- COGT 87.70
About BKU BankUnited Inc.
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.